Item 8.01 Other Events

On December 12, 2012, Illumina, Inc. received a request for additional information (also known as a "second request") from the U.S. Federal Trade Commission ("FTC") in connection with the FTC's review under the Hart-Scott-Rodino Act of Illumina's proposed acquisition of Complete Genomics, Inc. Illumina intends to continue to work collaboratively with the FTC staff in connection with its review of the proposed acquisition.

---